Weight change therapy as a potential treatment for end-stage ovarian carcinoma
- PMID: 24847411
- PMCID: PMC4025513
- DOI: 10.12659/AJCR.890229
Weight change therapy as a potential treatment for end-stage ovarian carcinoma
Abstract
Patient: Female, 41 FINAL DIAGNOSIS: Ovarian carcinoma Symptoms: Ascites • hepatomegaly • weight loss
Medication: - Clinical Procedure: - Specialty: Oncology.
Objective: Unusual or unexpected effect of treatment.
Background: The aim of this case report is to present the results of treatment of end-stage ovarian carcinoma in a 41-year-old women using weight loss therapy.
Case report: We describe the case of a female aged 41 years with epithelial invasive ovarian cancer of III-IV stage, T3N2M1. Concurrent diseases were: abdominal carcinomatosis; hepatomegaly; ascites; condition after laparocentesis and skin-abdominal fistula; condition after 6 courses of neo-adjuvant polychemotherapy; hypertension II stage, risk factor of 3-4; dyslipidemia; and metabolic syndrome. A weight loss method based on a very-low-calorie diet and physical activity was used. Body weight was reduced from 74 kg to 53 due to loss of adipose tissue after 6 months of therapy. At the same time, the percentages of water and muscle tissue were increased significantly. While overweight was reducing, clinical, laboratory, and instrumental results were improving. As a result of the weight loss therapy, about ≈100 mm-sized ovarian cancer was transformed into smaller-sized ovarian cysts.
Conclusions: An analgesic effect was also achieved without use of narcotic or non-narcotic analgesics. These cyto-reversible processes were documented by laboratory and instrumental data. The mechanisms behind these differences remain to be elucidated. Future research with a larger study cohort and longer follow-up is needed to further investigate the role of caloric restriction diet in cancer cell changes in ovarian cancer.
Keywords: Metabolic Syndrome X; Ovarian Neoplasms; Weight Loss.
Figures
Similar articles
-
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.Oncologist. 1996;1(5):326-330. Oncologist. 1996. PMID: 10388011
-
The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):88-98. doi: 10.11124/jbisrir-2015-1812. JBI Database System Rev Implement Rep. 2015. PMID: 26447010
-
The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma.Int J Gynecol Cancer. 2002 Sep-Oct;12(5):438-42. doi: 10.1046/j.1525-1438.2002.01171.x. Int J Gynecol Cancer. 2002. PMID: 12366659
-
[Surgery for advanced stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].Gynecol Obstet Fertil Senol. 2019 Feb;47(2):197-213. doi: 10.1016/j.gofs.2019.01.003. Epub 2019 Feb 19. Gynecol Obstet Fertil Senol. 2019. PMID: 30792175 Review. French.
-
Initial therapy for early ovarian carcinoma.Cancer. 1987 Oct 15;60(8 Suppl):2042-9. doi: 10.1002/1097-0142(19901015)60:8+<2042::aid-cncr2820601516>3.0.co;2-d. Cancer. 1987. PMID: 3308064 Review.
Cited by
-
Metabolic risk factors of ovarian cancer: a review.JBRA Assist Reprod. 2022 Apr 17;26(2):335-347. doi: 10.5935/1518-0557.20210067. JBRA Assist Reprod. 2022. PMID: 34751020 Free PMC article. Review.
-
Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.Oncogenesis. 2016 Feb 15;5(2):e193. doi: 10.1038/oncsis.2016.2. Oncogenesis. 2016. PMID: 26878387 Free PMC article. Review.
-
Role of the body mass index in the genesis of ascites in ovarian cancer: a forensic case and review of the literature.BMJ Case Rep. 2018 Dec 18;11(1):e226491. doi: 10.1136/bcr-2018-226491. BMJ Case Rep. 2018. PMID: 30567893 Free PMC article.
-
Case-control study of metabolic syndrome and ovarian cancer in Chinese population.Nutr Metab (Lond). 2017 Feb 28;14:21. doi: 10.1186/s12986-017-0176-4. eCollection 2017. Nutr Metab (Lond). 2017. PMID: 28261315 Free PMC article.
-
Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients.BMC Res Notes. 2016 Mar 5;9:143. doi: 10.1186/s13104-016-1959-9. BMC Res Notes. 2016. PMID: 26946138 Free PMC article.
References
-
- Schnipper LE, Smith TJ, Raghavan D, et al. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: The top five list for oncology. J Clin Oncol. 2012;30:1715–24. - PubMed
-
- Health of population of the Republic of Kazakhstan and activity of health organizations in 2010–1012 years (statistical material) Vol. 2013. Astana: Medinform; p. 346.
-
- Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;79:965–76. - PubMed
-
- Parmar MK, Ledermann JA, Colombo N, et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet. 2003;361(9375):2099–106. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials